<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="purposes requires written permission. Abstract Although hepatitis C virus (HCV)" exact="infection" post="is often associated with extrahepatic cutaneous manifestations such as"/>
 <result pre="of HCV RNA. Interestingly, the flares gradually subsided during continued" exact="treatment" post="with these drugs while her HCV RNA level paradoxically"/>
 <result pre="3], it is unclear whether HCV per se or hepatitis" exact="treatment" post="agents cause these diseases. Although recently developed interferon (IFN)-free"/>
 <result pre="Although recently developed interferon (IFN)-free therapies for HCV shorten the" exact="treatment" post="duration and alleviate sustained virologic responses [4], pegylated IFN"/>
 <result pre="to affect the cytokine cascade [7, 8], adverse effects of" exact="treatment" post="with IFN plus ribavirin are attributed to IFN. Accordingly,"/>
 <result pre="plus ribavirin administered subcutaneously to treat progressive liver disease, but" exact="treatment" post="was discontinued 2 months later, in March 2009, due"/>
 <result pre="RNA level was 7.4 × 102 Eq/mL. Four weeks of" exact="treatment" post="by topical application of corticosteroids did not ameliorate the"/>
 <result pre="lesions had disappeared. During those 8 weeks, she received no" exact="treatment" post="for hypertension. Since her blood pressure was high (165/110),"/>
 <result pre="as the recurrences that appeared within a month of starting" exact="treatment" post="with atenolol gradually subsided, HCV RNA levels increased. Thus,"/>
 <result pre="resolved within 3 days without any pigmentary change. Lymphocyte transformation" exact="tests" post="with several drugs were performed on a number of"/>
 <result pre="candesartan cilexetil was added again in June 2012. Oral challenge" exact="tests" post="of atenolol were performed with no observed recurrences in"/>
 <result pre="are associated, one might expect that patients with chronic HCV" exact="infection" post="who show FDE may have low-titer HCV RNA. Although"/>
 <result pre="triggered by IFN + ribavirin in a patient with HCV" exact="infection" post="supports this argument [10]. However, the immunopathologic mechanisms of"/>
 <result pre="lesions had been previously reported [14]. Since mycoplasms or viral" exact="infection" post="can increase the risk of multiple drug hypersensitivity [15],"/>
 <result pre="hepatitis C virus infectionBlood1997790(2)776829226178 3FerriCLa CivitaLMontiMLongombardoGGrecoFPaseroGet al.Can type C hepatitis" exact="infection" post="be complicated by malignant lymphoma?Lancet199511346(8987)14267 4ReddyKRBourlièreMSulkowskiMOmataMZeuzemSFeldJJet al.Ledipasvir and sofosbuvir"/>
 <result pre="and sofosbuvir in patients with genotype 1 hepatitis C virus" exact="infection" post="and compensated cirrhosis: an integrated safety and efficacy analysisHepatology2015762(1)798625846144"/>
 <result pre="challenge with amlodipine besilate. Table 1 Results of lymphocyte transformation" exact="tests" post="with several drugs Stimulation index (positive &amp;gt;1.8) 2011 2012"/>
</results>
